Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,845 | -3,237 | -1,808 | -942 | -26 |
| Depreciation Amortization | 293 | 159 | 23 | 3 | N/A |
| Accounts payable and accrued liabilities | -23 | 43 | -135 | 145 | 25 |
| Other Working Capital | -108 | 36 | -13 | 150 | 26 |
| Other Operating Activity | 886 | 255 | 386 | -90 | -25 |
| Operating Cash Flow | $-3,797 | $-2,743 | $-1,547 | $-735 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -548 | -1,052 | -46 | -46 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 105 | N/A |
| Investing Cash Flow | $-548 | $-1,052 | $-46 | $59 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,970 | 1,984 | 3,441 | 4,106 | N/A |
| Financing Cash Flow | $5,970 | $1,984 | $3,441 | $4,106 | $N/A |
| Beginning Cash Position | 3,466 | 5,278 | 3,430 | N/A | N/A |
| End Cash Position | 5,091 | 3,467 | 5,278 | 3,430 | N/A |
| Net Cash Flow | $1,625 | $-1,811 | $1,848 | $3,430 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,797 | -2,743 | -1,547 | -735 | N/A |
| Capital Expenditure | -548 | -1,052 | -46 | -46 | N/A |
| Free Cash Flow | -4,345 | -3,795 | -1,593 | -781 | 0 |